Literature DB >> 15240700

The E2F-1 transcription factor promotes caspase-8 and bid expression, and enhances Fas signaling in T cells.

Qingyu Cao1, Ying Xia, Mitra Azadniv, I Nicholas Crispe.   

Abstract

The immune system depends on the extensive proliferation of rare Ag-specific precursor T lymphocytes, followed by their differentiation, the delivery of effector function, and finally death by apoptosis. T cells that lack the E2F-1 transcription factor, which is activated as cells pass the restriction point and enter S phase, show defects in activation-induced cell death. We now report that E2F-1 increases the activity of an apoptotic pathway that is important in murine primary T cells. Thus, E2F-1 promotes the transcription of Bid, a molecule that links death receptor signaling to the activation of apoptotic mechanisms in mitochondria. It also promotes the transcription of caspase-8, the enzyme that cleaves and activates Bid. Enforced expression of Bid can partially restore apoptosis in E2F-1-deficient T cells. Thus, E2F-1 integrates cell cycle progression with apoptosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15240700     DOI: 10.4049/jimmunol.173.2.1111

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

1.  E2F1: a potential therapeutic target for systematic lupus erythematosus.

Authors:  Xin-Yu Fang; Dong-Qing Ye
Journal:  Rheumatol Int       Date:  2013-09-27       Impact factor: 2.631

2.  Disruption of mutually negative regulatory feedback loop between interferon-inducible p202 protein and the E2F family of transcription factors in lupus-prone mice.

Authors:  Ravichandran Panchanathan; Hong Xin; Divaker Choubey
Journal:  J Immunol       Date:  2008-05-01       Impact factor: 5.422

3.  Novel link between E2F1 and Smac/DIABLO: proapoptotic Smac/DIABLO is transcriptionally upregulated by E2F1.

Authors:  Wei Xie; Peng Jiang; Lin Miao; Ying Zhao; Zhai Zhimin; Li Qing; Wei-guo Zhu; Mian Wu
Journal:  Nucleic Acids Res       Date:  2006-04-14       Impact factor: 16.971

4.  E2f2 Attenuates Apoptosis of Activated T Lymphocytes and Protects from Immune-Mediated Injury through Repression of Fas and FasL.

Authors:  Noor Mustafa; Jone Mitxelena; Arantza Infante; Olatz Zenarruzabeitia; Ainhoa Eriz; Ainhoa Iglesias-Ara; Ana M Zubiaga
Journal:  Int J Mol Sci       Date:  2021-12-28       Impact factor: 5.923

5.  ROS production is essential for the apoptotic function of E2F1 in pheochromocytoma and neuroblastoma cell lines.

Authors:  Lilia Espada; Nathalie Meo-Evoli; Patricia Sancho; Sebastian Real; Isabel Fabregat; Santiago Ambrosio; Albert Tauler
Journal:  PLoS One       Date:  2012-12-12       Impact factor: 3.240

Review 6.  E2F1 death pathways as targets for cancer therapy.

Authors:  B M Pützer
Journal:  J Cell Mol Med       Date:  2007 Mar-Apr       Impact factor: 5.310

7.  The pro-apoptotic paradox: the BH3-only protein Bcl-2 interacting killer (Bik) is prognostic for unfavorable outcomes in breast cancer.

Authors:  Vrajesh Pandya; Darryl Glubrecht; Larissa Vos; John Hanson; Sambasivarao Damaraju; John Mackey; Judith Hugh; Ing Swie Goping
Journal:  Oncotarget       Date:  2016-05-31
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.